文献速递心外重症与机械循环支持

VA-ECMO支持急性大面积肺栓塞的恢复预测因素

Predictors of Recovery in Patients Supported With Venoarterial Extracorporeal Membrane Oxygenation for Acute Massive Pulmonary Embolism.
PubMed 文献 · Ann Thorac Surg · 2019-12-14

延长的呼吸困难、升高的NT-proBNP、扩大的肺动脉直径和静脉血栓栓塞史与需手术相关。基于这些因素构建的预测算法低风险评分阴性预测值97%、特异性97%,高风险评分阳性预测值100%、敏感性67%。无手术组90天生存率97%,手术组100%。

要点

  • 延长的呼吸困难、高NT-proBNP、扩大的肺动脉直径和VTE史预测需手术。
  • 预测算法低风险评分阴性预测值97%,高风险评分阳性预测值100%。

核心结论

  • 超过70%的大面积肺栓塞VA-ECMO支持患者最终仅用抗凝即可恢复。
  • 特定危险因素可能与血栓慢性化相关,并可用于考虑早期手术干预以缩短VA-ECMO时间。

研究设计与样本

  • 协议为VA-ECMO支持3至5天后通过超声心动图重新评估右心室功能。

主要发现

  • 与仅抗凝撤机相比,需SPE的相关因素包括延长的呼吸困难、升高的N末端脑钠肽前体、扩大的肺动脉直径和静脉血栓栓塞史。
  • 预测算法低风险评分阴性预测值97%、特异性97%;高风险评分阳性预测值100%、敏感性67%。
  • 90天生存率:no-SPE组97%,SPE组100%。

关键数值与推荐

  • VA-ECMO支持3至5天后超声心动图评估右心室功能,若恢复则撤机仅抗凝,若持续功能障碍则行SPE。
  • 低风险评分阴性预测值97%、特异性97%;高风险评分阳性预测值100%、敏感性67%。

临床怎么用

  • 对VA-ECMO支持的大面积肺栓塞患者,可按协议在3至5天后评估右心室功能决定是否需要SPE。
  • 存在延长的呼吸困难、高NT-proBNP、扩大的肺动脉直径或VTE史时,可考虑早期手术干预以缩短VA-ECMO时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has emerged as a promising initial support strategy for acute massive pulmonary embolism. However, it remains unclear which patients will ultimately require surgical pulmonary embolectomy (SPE) vs anticoagulation alone. METHODS: All consecutive patients (2015-2018) with confirmed massive PE, placed on VA-ECMO utilizing a protocolized approach, were reviewed. Per protocol, patients were supported for 3 to 5 days before reevaluation of right ventricular (RV) function via echocardiography. If RV function recovered, VA-ECMO was discontinued with no further intervention (no-SPE group). In patients with persistent RV dysfunction, SPE was performed. RESULTS: Forty-five patients were identified, and 41 patients were treated per protocol. Seventy-three percent responded to anticoagulation alone, and 27% required SPE. Factors associated with SPE rather than decannulation with anticoagulation alone included prolonged shortness of breath, elevated N-terminal prohormone of brain natriuretic peptide, enlarged pulmonary artery diameter, and history of venous thromboembolism. A predictive algorithm was developed with a negative predictive value of 97% and a specificity of 97% for a low-risk score, and a positive predictive value of 100% and sensitivity of 67% for a high-risk score. Overall, 90-day survival was 97% in the no-SPE group and 100% in the SPE group. CONCLUSIONS: In this cohort, greater than 70% of patients who presented with massive PE and supported with VA-ECMO ultimately recovered with anticoagulation alone. Specific risk factors, likely related to thrombus chronicity, may be associated with lack of RV recovery, and can be utilized for consideration of early surgical intervention to minimize VA-ECMO duration.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ghoreishi M, DiChiacchio L, Pasrija C, et al. Predictors of Recovery in Patients Supported With Venoarterial Extracorporeal Membrane Oxygenation for Acute Massive Pulmonary Embolism. Ann Thorac Surg. 2019. PMID: 31846635. doi:10.1016/j.athoracsur.2019.10.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。